secwatch.observer — SEC 8-K summary
======================================

Issuer:     CareDx, Inc. (CDNA)
CIK:        0001217234
Form:       8-K/A
Filed at:   2026-09-16T20:06:13+00:00
Accession:  0001217234-26-000052
Event type: m_and_a
Sentiment:  negative
Materiality: 0.55
Item codes: 9.01, 2.01
LLM model:  deepseek-v4-flash:cloud@v2

CareDx files Naveris 2025 financials: revenue $34.3M, net loss $3.9M, going concern doubt
--------------------------------------------------------------------------------

- Naveris FY2025 revenue $34.337M; net loss $3.882M; accumulated deficit $65.049M.
- Substantial doubt about going concern; recurring operating losses and negative operating cash flow.
- Cash and equivalents $15.401M plus restricted cash $0.890M at Dec 31, 2025.
- Naveris is commercial-stage precision oncology; NavDx TTMV-HPV DNA test for viral-induced cancers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1217234/000121723426000052/0001217234-26-000052-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1217234/000121723426000052/cdna-20260630.htm
  HTML page:      https://secwatch.observer/filing/0001217234-26-000052

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer